
He’s killing more people in the states that didn’t vote for him:
The Trump administration plans to rescind $600 million in public health funds from four states led by Democrats because it finds the grants “inconsistent with agency priorities,” according to documents reviewed by The New York Times.
The programs slated to be cut are in California, Colorado, Illinois and Minnesota. They include grants to state and local public health departments as well as to some nongovernmental organizations. A list of the cuts was shared with relevant congressional committees on Monday.
The funds are administered through the Centers for Disease Control and Prevention. They include grants given to states for a variety of purposes, including hiring staffs, modernizing data systems and managing disease outbreaks. Some programs are aimed at the needs of specific communities.
Some of the cuts will be finalized this week and others over the coming weeks, totaling roughly $600 million. The figure was first reported by The New York Post.
Nearly two-thirds of the funding is unspent money allocated to state and local public health departments in California.
“These grants are being terminated because they do not reflect agency priorities,” a spokesman for the Department of Health and Human Services said. About two dozen of the grants were aimed at curbing H.I.V. and other sexually transmitted infections.
You can lay this one at the feet of RFK Jr, the former Democrat who sold his soul to the devil so he could make people sicker with crackpot snake oil nonsense while telling people to eat healthier food, as if that’s some sort of revolutionary concept. Thanks Bobby. You must be so proud.
The vaccine maker Moderna said on Tuesday that the Food and Drug Administration had notified the company that the agency would not review its mRNA flu vaccine, the latest sign of federal health policy that has become hostile to vaccine development.
Dr. Vinay Prasad, the agency’s top vaccine regulator, rejected the company’s application for approval over a concern that Moderna’s clinical trial had compared its experimental vaccine against a product the agency did not consider the best on the market. People in the comparison group received Fluarix Quadrivalent, a flu vaccine sold by GSK.
Moderna had spent years and hundreds of millions of dollars testing its flu vaccine, enrolling 41,000 people and aimed at a market of adults ages 50 and older. The company concluded that its shot was superior to GSK’s product.
Stephen Hoge, the company’s president, said in an interview on Tuesday that the new flu vaccine was designed to be better tailored for a single nation than the ones that tended to be used by an entire hemisphere.
“This refusal to start a review is all confusing, to say the least,” Mr. Hoge said, adding: “It is surprising, and we’re trying to understand what has changed.”
They just don’t want people to be protected. They want us to die.








